New buy recommendation for Marinomed |

26.06.2020 The FMR analysts started covering Marinomed with the investment recommendation “Buy” and a target price of EUR 125.0. Image credits 1st IPO Marinomed Biotech, (© Wiener Börse AG / APA-Fotoservice / Hörmandinger photographer: Martin Hörmandinger and Richard Tanzer) >> Open at Shares on the radar:Addiko Bank, VIG, Austrian post, Warimpex, Mold, Marinomed Biotech, … Read more